Latest News about General
Recent news which mentions General
Boston Scientific Pauses Enrollment In Farapulse Study In Drug-Naive Patients With Irregular Heart Rhythm
October 23, 2024
From Benzinga
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
October 23, 2024
From Benzinga
SAG-AFTRA Reaches Over 120 AI Agreements, Negotiations With Activision, EA, WB Come Next
October 23, 2024
From Benzinga
Apple, Goldman Sachs Fined $89 Million Over Apple Card Missteps, Government Watchdog Orders Victim Compensation
October 23, 2024
From Benzinga
From Benzinga
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
October 23, 2024
From Benzinga
Ophthalmic Biopharmaceutical Ocuphire Pharma Shifts Focus To Gene Therapy Through Opus Genetics Stock Deal
October 23, 2024
From Benzinga
From Benzinga
Philip Morris' Q3 Driven By Smoke-Free Products Amid Rising Market Share In Key Regions: Analyst Forecasts Growth Across IQOS And ZYN Brands
October 23, 2024
From Benzinga
Penny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval Pathway
October 23, 2024
From Benzinga
Block To See Improved Profitability Amid Expense Discipline In Q3: Analyst Forecasts Stable Payment Volume Growth
October 23, 2024
From Benzinga
Neuropsychiatry-Focused Alto Neuroscience's Mid-Stage Depression Trial Disappoints, Analyst Notes Failure Raises Concerns About Platform
October 23, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.